Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Nitric Oxide During LVAD Implantation
2005-000326-24Phase 2Completed
- Sponsor
- Mallinckrodt Pharmaceuticals
- Start
- Jun 2005
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of nitric oxide in Right heart dysfunction (RHF), sponsored by Mallinckrodt Pharmaceuticals. Started Jun 2005; status: completed.
02
Drugs
nitric oxide
03
Conditions
Right heart dysfunction (RHF)
Beyond the preview
Go deeper on 2005-000326-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000326-24.